One study [38] suggests higher rates of BMB/PET discrepancies among elderly patients and those with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.